Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Kornmueller, K; Amri, EZ; Scheideler, M; Prassl, R.
Delivery of miRNAs to the adipose organ for metabolic health.
Adv Drug Deliv Rev. 2022; 181:114110 Doi: 10.1016/j.addr.2021.114110
Web of Science PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Kornmüller Karin
Prassl Ruth

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Despite the increasing prevalence of obesity and diabetes, there is no efficient treatment to combat these epidemics. The adipose organ is the main site for energy storage and plays a pivotal role in whole body lipid metabolism and energy homeostasis, including remodeling and dysfunction of adipocytes and adipose tissues in obesity and diabetes. Thus, restoring and balancing metabolic functions in the adipose organ is in demand. MiRNAs represent a novel class of drugs and drug targets, as they are heavily involved in the regulation of many cellular and metabolic processes and diseases, likewise in adipocytes. In this review, we summarize key regulatory activities of miRNAs in the adipose organ, discuss various miRNA replacement and inhibition strategies, promising delivery systems for miRNAs and reflect the future of novel miRNA-based therapeutics to target adipose tissues with the ultimate goal to combat metabolic disorders.
Find related publications in this database (using NLM MeSH Indexing)
Adipocytes - metabolism
Adipose Tissue - drug effects, metabolism
Diabetes Mellitus, Type 2 - physiopathology
Drug Delivery Systems - methods
Humans - administration & dosage
Insulin Resistance - physiology
Lipid Metabolism - physiology
Metabolic Diseases - physiopathology
MicroRNAs - administration & dosage, pharmacology

Find related publications in this database (Keywords)
Adipose tissues
miRNA therapeutics
Delivery systems
© Med Uni Graz Impressum